Ryuji Hayashi - University of Toyama

基本信息

Career Trajectory

Bio

Ryuji Hayashi currently works at University of Toyama. Ryuji does research in Clinical Immunology, Internal Medicine (General Medicine) and Oncology. Their most recent publication is 'Clinical Parameters for Predicting the Survival in Patients with Squamous and Non-squamous-cell NSCLC Receiving PD-1 Inhibitor Therapy'.

Research Interests

Papers共 110 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors: 1-Year Follow-Up of the FIRST-Dx Study

Junichi Matsubara, Kumi Mukai,Tomohiro Kondo,Masahiro Yoshioka,Hidenori Kage,Katsutoshi Oda,Sadakatsu Ikeda,Hiromichi Ebi,Kei Muro,Shinya Kajiura,Ryuji Hayashi,Reiko Ashida,Masayuki Kitano,Manabu Muto

Cancer science (2025)

Cited0Views0WOSBibtex

Multicenter Retrospective Analysis of Pulmonary Sarcomatoid Carcinoma Clinically Diagnosed Using Small Biopsy Specimens

Minehiko Inomata,Takeshi Tsuda,Tomomi Ichikawa,Masahiro Matsumoto,Isami Mizushima, Kenji Azechi,Naoki Takata, Nozomu Murayama, Zenta Seto,Kotaro Tokui, Yasuaki Masaki,Seisuke Okazawa,Shingo Imanishi,Toshiro Miwa,Ryuji Hayashi,Hirokazu Taniguchi

Cancer diagnosis & prognosisno. 3 (2025): 363-369

Cited0Views0WOSBibtex

Effectiveness of Chemoimmunotherapy in Small-cell Lung Cancer Patients with a Poor Performance Status or Higher Neutrophil/Lymphocyte Ratio

Minehiko Inomata,Naoki Takata,Zenta Seto,Nozomu Murayama,Kotaro Tokui,Seisuke Okazawa,Shingo Imanishi,Toshiro Miwa,Ryuji Hayashi,Shoko Matsui

IN VIVOno. 1 (2025): 467-472

Cited0Views0WOSBibtex

Prescription Pattern of Anamorelin; a Therapeutic Agent for Cancer Cachexia

Yoshihiro Tambo,Shinya Kajiura, Akihiro Yoshida,Shingo Chikaoka, Yuki Tanabe, Nahoko Kanai,Ando Takayuki,Akira Ueda, Iori Moto,Yurika Nakayama,Tomoko Shima, Yukiko Matsushita, Tatsuji Mizukami, Mosaburou Kainuma,Ichiro Yasuda,Ryuji Hayashi

JOURNAL OF PALLIATIVE MEDICINE（2024）

Cited0Views0WOSBibtex

HDAC Inhibitors Induce HLA Class I Molecules Through the SOX10-IRF1 Axis in Clear Cell Sarcoma Cells

Minh Thi Nguyen, Ryota Kikuchi, Soshi Nishibu,Yue Zhou,Hiroshi Moritake,Takuro Nakamura,Hidetatsu Outani,Ryuji Hayashi,Hiroaki Sakurai,Satoru Yokoyama

BIOLOGICAL & PHARMACEUTICAL BULLETINno. 11 (2024): 1913-1919

Cited0Views0WOSBibtex

Pituitary Apoplexy in Endocrinologically Silent Adenoma During Somatostatin Analog Administration for Pancreatic Neuroendocrine Tumor: A Case Report

Keitaro Shiraishi,Takuya Akai,Takahiro Tomita,Ryuji Hayashi,Takashi Minamisaka,Satoshi Kuroda

NEUROPATHOLOGY（2024）

Cited1Views0WOSBibtex

Molecularly Matched Therapies Identified by Comprehensive Genomic Profiling Before the First-Line Setting to Provide Alternative Treatment Outcomes in Patients with Solid Tumors: 1-Year Follow-Up of the Prospective FIRST-Dx Study

Ryuji Hayashi,Junichi Matsubara,Kumi Mukai,Masahiro Yoshioka,Hidenori Kage,Katsutoshi Oda,Sadakatsu Ikeda,Hiromichi Ebi,Kei Muro,Shinya Kajiura, Reiko Ashida,Masayuki Kitano,Manabu Muto

Journal of Clinical Oncologyno. 16_suppl (2024): 3137-3137

Cited0Views0Bibtex

Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient with Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case Report

Takahiro Hirai,Minehiko Inomata, Shuhei Minatoyama, Moe Hashizume,Naoki Takata,Kana Hayashi,Zenta Seto,Kotaro Tokui,Chihiro Taka,Seisuke Okazawa,Kenta Kambara,Shingo Imanishi,Toshiro Miwa,Ryuji Hayashi,Shinichi Tanaka,Akira Noguchi,Tsutomu Sato

In Vivono. 3 (2024): 1509-1511

Cited0Views0WOSBibtex

An Observational Study on the Efficacy of Targeted Therapy for Pulmonary Sarcomatoid Carcinoma

Discover Oncologyno. 1 (2024): 1-9

Cited0Views0WOSBibtex

Immune Checkpoint Inhibitor Therapy for Patients with Non-small Cell Lung Cancer Ineligible for Platinum Doublet Chemotherapy

Minehiko Inomata, Shuhei Minatoyama,Naoki Takata,Kana Hayashi,Takahiro Hirai,Zenta Seto,Kotaro Tokui,Chihiro Taka,Seisuke Okazawa,Kenta Kambara,Shingo Imanishi,Toshiro Miwa, Kei Matsuyama,Ryuji Hayashi, Shoko Matusi,Kazuyuki Tobe

Anticancer Researchno. 3 (2024): 1241-1245

Cited1Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn